tarlatamab
Interviews and expert commentary tagged “tarlatamab” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Oncology
Martin Wermke MD; ESMO 2025: Initial Therapy with Bi-Specific T-cell Engager Tarlatamab Promises Better Outcomes in Patients with Small Cell Lung Cancer
Tarlatamab, a bi-specific T-cell engager drug added to innitial immunochemotherapy brought encouraging initial survival outcomes in the DeLLphi-303 reported at the European Society for Medical Oncolog
27 October 2025
0:00